BVS 11.69 (+2.81%)
US09075A1088Medical Diagnostics & ResearchDiagnostics & Research

Bioventus (BVS) Stock Highlights

11.69 | +2.81%
2024-09-19 03:55:15
Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the bodys natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies.

Statistics

Range Today
11.27 11.99
Volume Today 525.8K
Range 1 Year
2.82 11.48
Volume 1 Year 79.73M
Range 3 Year
0.8 17.53
Volume 3 Year 315.92M
Range 10 Year
0.8 19.94
Volume 10 Year 349.01M

Highlights

Market Capitalization 728.14M (small)
Floating Shares 35.38M
Current Price 11.69
Price To Earnings -17
Price To Revenue 2.12
Price To Book 4.82
Earnings Per Share -0.65
Payout Ratio 0%

Performance

Latest +2.81%
1 Month +34.68%
3 Months +99.49%
6 Months +116.08%
1 Year +288.37%
3 Years -16.62%
5 Years -22.58%
10 Years -22.58%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.